IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.97% | 11.21% | 14.81% | 14.43% | 12.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.97% | 11.21% | 14.81% | 14.43% | 12.91% |
| Cost of Revenue | 18.53% | 16.52% | 15.20% | 15.38% | 13.22% |
| Gross Profit | 8.72% | 9.62% | 14.69% | 14.15% | 12.82% |
| SG&A Expenses | 2.46% | 4.86% | 7.66% | 11.45% | 12.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.66% | 9.21% | 11.09% | 12.46% | 11.36% |
| Operating Income | 16.12% | 15.73% | 23.42% | 19.04% | 16.55% |
| Income Before Tax | 15.62% | 14.25% | 20.85% | 16.83% | 13.98% |
| Income Tax Expenses | 24.48% | 24.43% | 26.61% | 16.66% | 14.91% |
| Earnings from Continuing Operations | 13.22% | 11.60% | 19.34% | 16.87% | 13.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.22% | 11.60% | 19.34% | 16.87% | 13.73% |
| EBIT | 16.12% | 15.73% | 23.42% | 19.04% | 16.55% |
| EBITDA | 18.13% | 18.61% | 25.36% | 19.88% | 16.62% |
| EPS Basic | 12.66% | 11.08% | 18.80% | 16.38% | 13.24% |
| Normalized Basic EPS | 14.28% | 12.93% | 19.48% | 15.49% | 13.44% |
| EPS Diluted | 13.20% | 10.53% | 18.23% | 16.63% | 13.13% |
| Normalized Diluted EPS | 14.49% | 12.95% | 19.39% | 15.30% | 13.25% |
| Average Basic Shares Outstanding | 0.51% | 0.48% | 0.45% | 0.41% | 0.43% |
| Average Diluted Shares Outstanding | 0.31% | 0.44% | 0.52% | 0.59% | 0.60% |
| Dividend Per Share | 17.65% | 16.67% | 15.63% | 51.06% | 51.11% |
| Payout Ratio | 0.71% | 0.75% | 0.64% | -0.06% | -0.37% |